Reviews
Vol. 65 No. 5 (2013)
https://doi.org/10.4081/reumatismo.2013.207

Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 2 September 2013
Published: 18 December 2013
5064
Views
2778
Downloads
Recommendations, Evidence-based medicine, Methotrexate, Rheumatoid arthritis, Rheumatic diseases.
rheumatology, arthritis

Authors

M. Todoerti
Rheumatology, IRCCS S. Matteo, University of Pavia, Italy.
W. Maglione
Rheumatology, Istituto Ortopedico G. Pini, Milan, Italy.
E. Bernero
Rheumatology, University of Genoa, Italy.
A. Bortoluzzi
Rheumatology, University of Ferrara, Italy.
M. Colaci
michelecolaci@virgilio.it
Rheumatology, University of Modena and Reggio Emilia, Italy.
E. Galuppi
Rheumatology, University of Ferrara, Italy.
S. Paolino
Rheumatology, University of Genoa, Italy.
R. Talarico
Rheumatology, University of Pisa, Italy.
M. Cutolo
Reumatologia, Università di Genova, Italy.
C. Ferri
Rheumatology, University of Modena and Reggio Emilia, Italy.
F. Trotta
Rheumatology, University of Ferrara, Italy.
S. Bombardieri
Rheumatology, University of Pisa, Italy.
C.M. Montecucco
Rheumatology, IRCCS S. Matteo, University of Pavia, Italy.
L. Sinigaglia
Rheumatology, Istituto Ortopedico G. Pini, Milan, Italy.
The objective of this review is to update the recommendations of the 2010 Italian Consensus on the use of methotrexate (MTX) in rheumatoid arthritis (RA) and other rheumatic diseases. The literature published between 2008 and 2012 was systematically reviewed and updated recommendations on MTX use in rheumatic diseases, particularly RA, were formulated. These recommendations were approved by a panel of expert Italian Rheumatologists. A total of 10,238 references were identified, among which 70 studies were selected for critical evaluation. Sufficient evidence had accumulated to warrant changes to several of the recommendations in the new version. A new recommendation for patients with RA who are in MTX-induced clinical remission was also proposed and approved by the panel. Updated recommendations for the use of MTX in patients with RA or other rheumatologic disease are proposed.

Downloads

Download data is not yet available.

How to Cite



1.
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. Reumatismo [Internet]. 2013 Dec. 18 [cited 2026 Aug. 27];65(5):207-18. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2013.207

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.